Clear Search sequence regions


  • diagnosis (2)
  • humans (1)
  • lung cancer (1)
  • lung diseases (1)
  • mass (7)
  • research (1)
  • Sizes of these terms reflect their relevance to your search.

    Mass Spectrometry Imaging (MSI) represents a novel and advancing technology that offers unparalleled in situ characterization of tissues. It provides comprehensive insights into the chemical structures, relative abundances, and spatial distributions of a vast array of both identified and unidentified endogenous and exogenous compounds, a capability not paralleled by existing analytical methodologies. Recent scholarly endeavors have increasingly explored the utility of MSI in the adjunct diagnosis and biomarker research of pulmonary disorders, including but not limited to lung cancer. Concurrently, MSI has proven instrumental in elucidating the spatiotemporal dynamics of various pharmacological agents. This review concisely delineates the fundamental principles underpinning MSI, its applications in pulmonary disease diagnosis, biomarker discovery, and drug distribution investigations. Additionally, it presents a forward-looking perspective on the prospective trajectories of MSI technological advancements. Copyright © 2024 Elsevier B.V. All rights reserved.

    Citation

    Chunliu Guan, Lu Kong. Mass spectrometry imaging in pulmonary disorders. Clinica chimica acta; international journal of clinical chemistry. 2024 Jul 15;561:119835

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 38936534

    View Full Text